Fibrosing cholestatic hepatitis after kidney transplantation from HCV ‐viremic donors to HCV ‐negative recipients: A unique complication in the DAA era-Reference-Cited by-同舟云学术

Fibrosing cholestatic hepatitis after kidney transplantation from HCV ‐viremic donors to HCV ‐negative recipients: A unique complication in the DAA era

Published:2019-09-18 Issue:2 Volume:20 Page:600-605
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Kapila Nikhil¹²^ORCID,Al‐Khalloufi Kawtar³,Bejarano Pablo A.⁴,Vanatta Jason M.³,Zervos Xaralambos B.³

Affiliation:

1. Department of Gastroenterology and Hepatology Cleveland Clinic Florida Weston Florida

2. Division of Transplant Hepatology Duke University Durham North Carolina

3. Department of Transplant Cleveland Clinic Florida Weston Florida

4. Department of Pathology Cleveland Clinic Florida Weston Florida

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.15583

Reference19 articles.

1. Hepatitis B virus reinfection after orthotopic liver transplantation;O'Grady JG;Serological and clinical implications. J Hepatol,1992

2. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis

3. Cholestatic hepatitis C following liver transplantation: An outcome-based histological definition, clinical predictors, and prognosis

4. Fibrosing cholestatic hepatitis in hepatitis C virus‐infected renal transplant recipients;MunozDeBustillo E;J Am Soc Nephrol,1998

5. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expanding the liver donor pool worldwide with hepatitis C infected livers, is it the time?;World Journal of Transplantation;2024-06-18

2. Fibrosing cholestatic hepatitis as a variant of the course of hepatotropic viruses’ infection;Epidemiology and Infectious Diseases;2024-06-10

3. Hepatitis C viremic lung transplantation to aviremic recipients: Comprehensive outcomes and post‐transplant viremia;Clinical Transplantation;2024-05

4. SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024;Saudi Journal of Gastroenterology;2024-01

5. Twelve‐month kidney and liver outcomes of kidney transplantation from Hepatitis C Viremic deceased donors to aviremic recipients;Transplant Infectious Disease;2023-12-19